156 results
Page 5 of 8
8-K
6l65l9 x6w4r93xod8d
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-99.1
sbzq8s
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.1
3pkhl2 mhj
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.3
6tgzid
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.1
civw2
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am
8-K
EX-2.1
59v l22p70fp8
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-10.1
5m2iemb
24 Mar 20
Departure of Directors or Certain Officers
4:15pm
424B5
1f5mmdfj0ip80 1u
31 Dec 19
Prospectus supplement for primary offering
4:28pm
8-K
EX-10.1
fl35a8jx09f0vmixxl
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
znrg jbip8t56sy8
3 Dec 19
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.1
qak5f1hry7
3 Dec 19
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.2
ibt1 8dhy2
3 Dec 19
Departure of Directors or Certain Officers
6:55am